Macro...
Cons:
- Inquisition on Pharmas start up again
- Spending on prescription drugs topped $954 billion in 2011 in Europe and North America but have been on a decline since then.
- New tech... Gene, Immuno and nano theraphy etc
Pro:
- Although somewhat wayning in Europe and North America in recent years, the ageing and long living but largely unhealthy population should increase demand.
- Growth in pharma use in emerging countries has outpaced in Europe and North America.
- The best-selling drug patents have expired or about to expire to name a few - Lipitor, Humira, Enbrel, Remicade, Abilify, Nexium...
Macro... Cons: - Inquisition on Pharmas start up again -...
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.41 |
Change
-0.665(9.41%) |
Mkt cap ! $552.9M | |||
| Open | High | Low | Value | Volume |
| $7.03 | $7.03 | $6.38 | $1.982M | 298.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 12754 | $6.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.41 | 1436 | 6 |
View Market Depth
| Last trade - 12.02pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$6.40 |
Change
-0.665 ( 9.42 %) |
||||
| Open | High | Low | Volume | ||
| $6.99 | $7.00 | $6.37 | 53453 | ||
| Last updated 12.21pm 14/05/2024 ? | |||||
| MYX (ASX) Chart |